Sava Technologies Secures £14,300,000 Investment for Growth
Revolutionizing Health Monitoring: Sava Technologies Secures Significant Investment
Sava Technologies, a groundbreaking company based in London, UK, has just made headlines by successfully raising £14,300,000 in Series A funding. This impressive funding round was led by renowned investors at Balderton Capital and Pentland Ventures, with notable participation from a range of other investors including Norrsken VC, JamJar Investments, True, Italian Founders Fund, Athletico Ventures, SOLO Investments, and Exceptional Ventures. This influx of capital underscores the growing interest in real-time health monitoring technology and its potential to transform the way we manage our health.
The funds raised will be pivotal for Sava as they aim to expedite regulatory approval and the commercial launch of their innovative wearable biosensor platform.
Founded by visionaries Renato Circi and Rafaël Michali, Sava is focused on developing a device that can detect important health-related molecules just beneath the skin. With their cutting-edge microsensor technology, Sava is on a mission to provide a painless and cost-effective solution for continuous health monitoring. The initial focus on glucose monitoring is just the beginning, as their platform holds the promise of revolutionizing how we approach health diagnostics.
With this latest funding round, Sava has now attracted a total of $32M in investment, highlighting the confidence investors have in their pioneering approach to health technology. For startup founders and investors alike, this case serves as a compelling reminder of the immense opportunities that exist within the health tech space. As we look towards the future, Sava Technologies is poised to not only lead the charge in wearable health monitoring but also to shape the landscape of consumer and medical devices, making the prospect of investing in such innovative ventures ever more enticing.
Key Terms Explained
- Series A funding
- The first significant round of venture capital financing. It is intended to help startups with a proven business model grow through product development and building a customer base.
- Regulatory approval
- A process in which a given governmental body or agency grants its consent or authorization for a product (often medical or pharmaceutical) to be marketed and sold.
- Wearable biosensor platform
- A technological platform that encompasses devices worn by the user, capable of detecting and monitoring various biological parameters or molecules, typically for health-related purposes.
Frequently Asked Questions
- How much funding has Sava Technologies recently raised?-Sava Technologies has recently raised £14,300,000 in Series A funding round.
- What is the main focus of Sava Technologies?+
- Who led the funding round for Sava Technologies?+
- What is the total amount of investment attracted by Sava Technologies till date?+
- What are the potential applications of Sava's wearable biosensor platform?+
They've invested in Sava Technologies
Get to know these Healthtech investors
| Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|
 Balderton Capital | 14 investments investments | 12 contacts contacts | |||
 Pentland Ventures | 2 investments investments | more info | |||
 Norrsken VC | 3 investments investments | 10 contacts contacts | |||
 JamJar Investments | 5 investments investments | 4 contacts contacts | |||
 True | 6 investments investments | 10 contacts contacts | |||
 Italian Founders Fund | 1 investment investment | more info | |||
 Athletico Ventures | 1 investment investment | more info | |||
 SOLO Investments | 1 investment investment | more info | |||
 Exceptional Ventures | 23 investments investments | 5 contacts contacts |
Click here for a full list of 7,526+ startup investors in the UK